Alexander C. Fanaroff, MD
Cardiology
Accepting new patients
Sees patients age 18 and up
Penn Heart and Vascular Center
Penn Medicine Provider

About me

  • Assistant Professor of Medicine (Cardiovascular Medicine) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Duke University School of Medicine
  • Residency: Duke University Medical Center
  • Fellowship: Duke University Medical Center

What my patients think about me

Average Rating

125 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

November 2025
good visit
September 2025
very knowledgeable
August 2025
assessing and evaluating issues.
July 2025
personal attention & listens

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Fanaroff is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Secemsky EA, Sato R, Williams AO, Fanaroff AC, Duval S, Jaff MR, Greenberg-Worisek A, Giri J, Wifler W, Monteleone P. Interplay of Race and Community Characteristics on Health Disparities Among Medicare Beneficiaries With Peripheral Artery Disease , Am J Cardiol: 2025


Patel N, Whitman C, Lieberman A, Blady S, Morse C, Naseer N, Weaver J, Ogunniyi MO, Kohn R, Volpp KG, Halpern SD, Morris AA, Stephens-Shields A, Fanaroff AC. A series of randomized trials of behavioral economic interventions to increase racial and ethnic diversity of research participants: Rationale and design of ITERATE , Am Heart J, 286: 2025,80-87


Sammour YM, Khan SU, Hong H, Wu J, Fanaroff AC, Reed GW, Poudel R, Thomas K, Ni Z, Goyal A, Kirtane AJ, Yeh RW, Jones WS, Goel SS, Jaber WA, Kleiman NS. Institutional Variability in Processes of Care and Outcomes Among Patients With STEMI in the US , JAMA Cardiol, 10: 2025,787-796


Lopes RD, Fanaroff AC. Factor XI inhibition for ACS patients: premises and prospects , EuroIntervention, 21: 2025,e776-e777


Russell LB, Volpp KGM, Patel MS, Chokshi NP, Coratti S, Farraday D, Norton L, Rareshide C, Zhu J, Klaiman T, Szymczak JE, Small DS, Fanaroff AC. Cost-Effectiveness of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular Disease , Circ Cardiovasc Qual Outcomes, 18(7): 2025,e011839


Schneider DJ, McMahon SR, Angiolillo DJ, Fanaroff AC, Ibrahim H, Hohl PK, Wanamaker BL, Effron MB, DiBattiste PM; the investigators. Prognostic implications over time of platelet FcɣRIIa expression in patients with myocardial infarction: a secondary analysis , J Invasive Cardiol: 2025


Wilson TM, Sarris-Michopoulos PM, Siddiqui R, Ahmed A, Riaz I, Licitra G, Ossi J, Khawaja M, Fanaroff AC, Maehara A, Capodanno D, Krittanawong C. Precision management of coronary in-stent restenosis , Trends Cardiovasc Med: 2025


Mehta M, Fanaroff AC, Rhodes CM, Xiong A, Snider CK, Fagen EM, Harhay MO, Mehrabyan N, Peifer MK, Volpp KG, Delgado MK Change in Default Prescription Length and Statin Prescribing Behavior , JAMA Intern Med, 185(6): 2025,736-739


Ryu E, Farraday D, Fanaroff AC, Coratti S, Chokshi NP, Zhu J, Szymczak JE, Russell LB, Norton L, Small D, Volpp KG, Klaiman T. What motivates participants: a qualitative analysis of gamification and financial incentives to increase physical activity , BMC Public Health, 25: 2025,1804


Fanaroff AC, Huang Q, Norton LA, Kellum WE, Eichelberger D, Wood JC, Bricker Z, Dooley Wood AG, Kemmer G, Smith JI, Adusumalli S, Putt ME, Volpp KG. Encouraging Pharmacist Referrals for Evidence-Based Statin Initiation: Two Pragmatic Cluster-Randomized Clinical Trials. , JAMA Cardiol, 10(5): 2025,473-481